These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12739832)

  • 1. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
    Singh NP; Mandal SK; Thakur A; Kapoor D; Anuradha S; Prakash A; Kohli R; Agarwal SK
    Ren Fail; 2003 Mar; 25(2):255-66. PubMed ID: 12739832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
    Jha R; Lakhtakia S; Jaleel MA; Narayan G; Hemlatha K
    Ren Fail; 2001 Sep; 23(5):629-36. PubMed ID: 11725909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination.
    Evans TG; Schiff M; Graves B; Agosti J; Barritt ML; Garner D; Holley JL
    Clin Nephrol; 2000 Aug; 54(2):138-42. PubMed ID: 10968690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
    Kapoor D; Aggarwal SR; Singh NP; Thakur V; Sarin SK
    J Viral Hepat; 1999 Sep; 6(5):405-9. PubMed ID: 10607257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients.
    Anandh U; Bastani B; Ballal S
    Am J Nephrol; 2000; 20(1):53-6. PubMed ID: 10644869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus vaccine in lymphoproliferative disorders: a prospective randomized study evaluating the efficacy of granulocyte-macrophage colony stimulating factor as a vaccine adjuvant.
    Yağci M; Acar K; Sucak GT; Yamaç K; Haznedar R
    Eur J Haematol; 2007 Oct; 79(4):292-6. PubMed ID: 17655695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GM-CSF in combination with hepatitis B vaccine on revacination of healthy adult non-responders.
    Lin C; Zhu J; Zheng Y; Chen Y; Wu Z; Chong Y; Gao Z
    J Infect; 2010 Apr; 60(4):264-70. PubMed ID: 20138189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
    Kayataş M
    Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis.
    Cruciani M; Mengoli C; Serpelloni G; Mazzi R; Bosco O; Malena M
    Vaccine; 2007 Jan; 25(4):709-18. PubMed ID: 16963165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Fabrizi F; Ganeshan SV; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Sep; 24(5):789-96. PubMed ID: 16918882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection.
    Navarro JF; Teruel JL; Mateos ML; Marcen R; Ortuno J
    Am J Nephrol; 1996; 16(2):95-7. PubMed ID: 8919223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood dendritic cells and GM-CSF as an adjuvant for hepatitis B vaccination in hemodialysis patients.
    Verkade MA; van de Wetering J; Klepper M; Vaessen LM; Weimar W; Betjes MG
    Kidney Int; 2004 Aug; 66(2):614-21. PubMed ID: 15253714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete success of intradermal vaccination against hepatitis B in advanced chronic renal failure and hemodialysis patients.
    Vlassopoulos D; Arvanitis D; Lilis D; Hatjiyannakos D; Louizou K; Hadjiconstantinou V
    Ren Fail; 1997 May; 19(3):455-60. PubMed ID: 9154662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
    Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
    J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte macrophage colony stimulating factor augmented hepatitis B vaccine protocol for rapid seroprotection in voluntary kidney donors.
    Krishnamurthy K; John GT; Abraham P; Jacob CK
    Indian J Med Res; 2004 Apr; 119(4):162-4. PubMed ID: 15147122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
    Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
    Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on hepatitis B vaccination in haemodialysis patients.
    Hess G; Kreiter F; Kösters W; Deusch K
    J Viral Hepat; 1996 May; 3(3):149-53. PubMed ID: 8871874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.